ClinicalTrials.gov
public full text
Public Domain
HHV8 and Solid Organ Transplantation
Solid organ transplant candidates will undergo serological screening for HHV8 at time of listing and transplantation. In the event of a recipient/donor mismatch R-/D+ or in the presence of a seropositive recipient (R+), blood levels of HHV8 DNA will be monitored together with specific IGRA for HHV8.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recommendations for HLA Genotyping Data Standards and Clinical Laboratory Staffing Considerations.#122853
- The Validity of Central Venous to Arterial Co2 Difference During Living Donor Liver Transplantation#866463
- HHSP23337001 — SEV1TECH, LLC — Department of Health and Human Services ($39,739,915)#601861
- Transparent Vessels?: What Organ Donors Should Be Allowed to Know about Their Recipients#719031
- Internal Jugular Vein Distensibility in Assessment of Fluid Responsiveness in Donors of Living Donor Liver Transplantation#1161979
Record · ID 855065
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive